Celyad Oncology appoints Dr. Georges Rawadi as CEO

– BELGIUM, Mont-St-Guibert – Celyad Oncology (EBR: CYAD | Nasdaq: CYAD), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced the appointment of Dr.